Patent · US Active

Imatinib production process

US7550591B2 · kind B2 · utility

4Cited by
2References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 2, 2007
Grant dateJun 23, 2009
Priority date
Expiry dateMay 2, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D295/155
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is a process for producing imatinib and salts thereof, e.g., imatinib mesylate. The process includes reacting 4-(4-methyl-piperazin-1-ylmethyl)-benzoic acid with N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine in the presence of a carboxylic acid coupling reagent, to produce imatinib, and optionally converting the imatinib into a salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.